Point-of-Care Glucose Analyzer Promotion HemoCue® Glucose 201 CLIA Waived

Features

• The HemoCue® Glucose 201 System is intended for the the quantitative determination of the instant blood glucose concentration in circulation supplements the clinical evidence in the diagnosis and treatment of patients with diabetes Hemocue glucose testing systems are based on a glucose dehydrogenase method and consist of a small dedicated analyzer and a unique disposable microcuvette No calibration or microcuvette batch-to-batch variations Glucose 201 analyzer: 0-444 mg/dl (0-24.6 mmol/l) Only 5 µL of capillary
• venous
• or arterial blood is needed Following the three simple steps
• the hemocue glucose systems will produce lab-accurate results for diagnosing or monitoring diabetes
• as well as monitoring neonatal blood glucose levels Contains an exact quantity of dry reagent that automatically yields a chemical reaction when in contact with blood